Neovasc Inc. Announces Publication of Positive Tiara Preclinical Data in the Journal JACC: Cardiovascular Interventions

barbara.lempert -Preclinical Studies Show Innovative Transcatheter Product to Treat Mitral Regurgitation is Safe, Technically Feasible and Results in a Well-Functioning Mitral Bioprosthesis- ...

Repros plummets as FDA questions testosterone drug data

Damian Garde Repros has again swung southward in its up-and-down development of the testosterone drug Androxal, pushing back its proposed NDA filing and revealing that the FDA is taking ...

Regeneron and Bayer’s Eylea turns out positive BRVO trial data

Carly Helfand The positive data keep rolling in for Regeneron's Eylea. Monday, the company said its blockbuster eye drug improved vision loss in patients with a condition caused ...

Galectin Therapeutics Preclinical Data Published in PLOS ONE

barbara.lempert    Galectin Therapeutics’ Preclinical Data Published in PLOS ONE Show Its Galectin Inhibitors Reverse Cirrhosis and Significantly Reduce Fibrosis and ...

Worried about Novartis’ rep, pharma chief cuts Japanese execs’ pay till data probe resolved

Tracy Staton Novartis pharma chief David Epstein isn't worried about Japanese sales of the blood pressure drug Diovan. He's "much more worried" about the Swiss drugmaker's ...

Takeda Shares Data for Norovirus Vaccine

mia.burns Takeda Highlights Data from Clinical Trial of Investigational Norovirus Vaccine Candidate Results of Phase 1/2 Study Show Reduction in Disease Severity Following ...

Tekmira Presents TKM-PLK1 Data

mia.burns Tekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference New Data Shows Positive Chromogranin-A Biomarker Results in ...

Novartis, Biogen Idec release more strong data on hot-selling MS pills

Carly Helfand The day after showing that two of their respective therapies provided better results with earlier treatments, the companies followed up with analyses of safety and brain ...

Ray of hope in Merck cost-cutting gloom: New cancer-immunotherapy data

Tracy Staton While headlines focused on Merck's 8,500-job, $ 2.5 billion restructuring yesterday, the pharma giant quietly posted promising early-stage data on what has become ...

AstraZeneca CEO celebrates 1st anniversary with promising lung cancer data

John Carroll The promising early results on AstraZeneca's lung cancer drug AZD9291 won't convince anyone that the troubled company is on the turnaround trail, but it's a ...

New Lucentis Data Reinforces Profile Across Four Indications

mia.burns New data for Novartis drug Lucentis® reinforces transformational efficacy and well-established safety profile across four indications     Pivotal myopic CNV trials ...

Roche’s new round of lung cancer data keeps spotlight on immunotherapies

John Carroll FierceBiotech News
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS